RAC 11.1% $1.37 race oncology ltd

Ann: Impressive Preclinical Bisantrene Breast Cancer Results, page-7

  1. 2,461 Posts.
    lightbulb Created with Sketch. 354
    Today is a great day. We're getting closer to getting bisantrene to those who really need it!

    Us shareholders will also be rewarded with the SP starting to reach fair value.

    This is another reminder of how effective bisantrene is as a cancer fighting drug and how much safer it is to use when compared to other chemo style drugs.

    Well done to the team for finding this and resurfacing its use. Now to hope it gets across the line when it comes to FDA approval.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.37
Change
-0.170(11.1%)
Mkt cap ! $232.5M
Open High Low Value Volume
$1.48 $1.48 $1.36 $632.2K 451.7K

Buyers (Bids)

No. Vol. Price($)
1 76 $1.37
 

Sellers (Offers)

Price($) Vol. No.
$1.39 4136 2
View Market Depth
Last trade - 16.10pm 05/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.